ストックスクリーナーアプリを入手
1.29
9.32%
0.11
アフターアワーズ：
1.27
-0.02
-1.55%
前日終値:
$1.18
開ける：
$1.2
24時間の取引高:
401.69K
Relative Volume:
2.36
時価総額：
$57.91M
収益：
$80.28M
当期純損益:
$-38.83M
株価収益率:
-1.5509
EPS:
-0.8318
ネットキャッシュフロー:
$-28.67M
1週間 パフォーマンス:
+42.53%
1か月 パフォーマンス:
+98.46%
6か月 パフォーマンス:
+60.63%
1年 パフォーマンス:
-14.57%
1日の値動き範囲:
$1.18
$1.33
1週間の範囲:
$0.85
$1.33
52週間の値動き範囲:
$0.5011
$1.685
Tela Bio Inc Stock (TELA) Company Profile
名前
Tela Bio Inc
セクター
電話
484-320-2930
住所
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.29 | 43.55M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
102.23 | 176.41B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.77 | 116.35B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
280.13 | 105.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.55 | 62.29B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.25 | 48.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 開始されました | Lake Street | Buy |
| 2019-12-03 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-12-03 | 開始されました | Jefferies | Buy |
| 2019-12-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Tela Bio Inc (TELA) 最新ニュース
Reverse split of up to 1-for-15 heads to a vote at TELA Bio (NASDAQ: TELA) after Nasdaq bid-price warning - Stock Titan
TELA Bio Inc. (TELA) Edges Higher on Renewed Buying Interest Near Key Support ZoneMoving Average Crossovers - dars.gov.et
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com South Africa
TELA Bio Cuts 41 Jobs as Losses Pressure Cash Position - MyChesCo
Malvern's TELA Bio Cuts Costs 18% and Parts Ways With Longtime COO/CFO Roberto Cuca - BioBuzz
Tela Bio CEO Heather Getz buys $8,311 in company stock - Investing.com
TELA Bio Announces $17 Million Annual Cost Reduction and CFO Change Amid Restructuring - Kalkine Media
TELA Bio Cuts Annual Costs by $17 Million as COO-CFO Departs - citybiz
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com India
TELA Looks 52.3% Undervalued on GF Value™ Despite Operational Ch - GuruFocus
TELA Bio Implements Workforce Cuts and Leadership Changes - TipRanks
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative - GlobeNewswire
Tela Bio Inc (TELA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
TELA Bio (TELA) CEO adds 12,500 shares in August buy - Stock Titan
TELA Bio (TELA) Q2 2026 Earnings Call Transcript - AOL.com
TELA (TELA) Quarter in Focus: The EPS Result Is Below Expectation under the Current Snapshot; Market Response: The Share Price Sheds 1.08% in the Available RecordProduct Revenue Analysis - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayKAMA Signal - vinanet.vn
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stak - GuruFocus
TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens - MyChesCo
TELA Bio (TELA) CEO buys 15,000 shares at $0.6978 - Stock Titan
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares - Stock Titan
TELA BIO (TELA): SilverArc Capital and Devesh Gandhi disclose 2.14M-share 4.8% stake - Stock Titan
TELA Bio, Inc. (NASDAQ:TELA) Just Reported And Analysts Have Been Cutting Their Estimates - Moomoo
TELA Bio (TELA) Drops 5.86% to $0.68 as Micro-Cap Med-Tech Stock Approaches Critical SupportOvernight Profile - vinanet.vn
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
TELA Bio, Inc. Revenue Breakdown – NASDAQ:TELA - TradingView
TELA Bio, Inc. Revenue Breakdown – BOATS:TELA - TradingView
TELA Bio, Inc. 2026: Revenue $19.29M, EPS ($0.2) — 10-Q Summary - TradingView
TELA Bio (NASDAQ: TELA) faces going concern doubt amid debt covenants and cash burn - Stock Titan
TELA Bio loss hits USD 9.3M in Q2 2026 - Medical Buyer
TELA BIO (TELA): SilverArc and Devesh Gandhi report 4.8% ownership stake - Stock Titan
TELA Bio, Inc. Stock 12‑Month Price Target Cut to $2.1, Implies 126% Upside - TradingView
TELA Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 12.4%One-Time Loss Impact - vinanet.vn
Tela Bio earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigati - GuruFocus
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... - Yahoo Finance
TELA Bio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
TELA Looks 43.6% Undervalued on GF Value™ Despite Operational Un - GuruFocus
Transcript : TELA Bio, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
TELA Bio misses Q2 revenue, withdraws full-year guidance - scanx.trade
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: TELA Bio misses Q2 2026 estimates, withdraws guidance - Investing.com
Is TELA Bio Inc (TELA) Positioned for Recovery After Q2 Earnings Miss? GF Score: 57/100 - GuruFocus
Q2 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook - TradingView
TELA Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
TELA Bio Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million - TradingView
TELA Bio Withdraws 2026 Revenue Guidance as Sales Fall 4% - Stock Titan
Tela Bio Inc (TELA) 財務データ
収益
当期純利益
現金流量
EPS
Tela Bio Inc (TELA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Capper Joseph H | Director |
Sep 14 '26 |
Buy |
1.02 |
25,000 |
25,502 |
54,827 |
| Getz Heather C | Chief Executive Officer |
Aug 17 '26 |
Buy |
0.66 |
12,500 |
8,311 |
532,500 |
| Getz Heather C | Chief Executive Officer |
Aug 14 '26 |
Buy |
0.70 |
15,000 |
10,467 |
520,000 |
| EW HEALTHCARE PARTNERS FUND 2, | 10% Owner |
Nov 17 '25 |
Buy |
1.11 |
3,604,000 |
4,000,440 |
7,714,709 |
2.61%
1.50%
大文字化:
|
ボリューム (24 時間):